Have you or your loved ones been diagnosed with hemophilia a?

You may be eligible to participate in a hemophilia a clinical trial.

Have you or your loved ones been diagnosed with hemophilia a? You may be eligible to participate in a hemophilia a clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Hemophilia A Clinical Trial
NCT02172950 | Phase 3 | Interventional
CSL Behring
Sponsored by
CSL Behring

Have you or your loved ones been diagnosed with hemophilia a?

You may be eligible to participate in a hemophilia a clinical trial.

Have you or your loved ones been diagnosed with hemophilia a? You may be eligible to participate in a hemophilia a clinical trial.

Active not recruiting

Male

All ages

This study has recruited 245 Participants

This multicenter, open-label, phase 3 extension study will investigate the safety and efficacy of rVIII‑SingleChain for prophylaxis and on‑demand treatment of bleeding episodes in 50 previously untreated patients (PUPs) with no previous exposure to any FVIII product who achieve at least 50 EDs to rVIII-SingleChain in this study. A substudy (open to both PTPs and PUPs) will investigate the use of rVIII-SingleChain in surgery. A substudy (open to PUPs who develop an inhibitor to rVIII-SingleChain) will investigate the use of rVIII-SingleChain in immune tolerance induction (ITI) therapy.

Available locations
Study Site 7240008

Study Site 7240008

Active not recruiting A Coruna, ESP 15006

Study Site 5280006

Study Site 5280006

Active not recruiting Amsterdam Zuidoost, NLD 1105 AZ

Study Site 8400241

Study Site 8400241

Active not recruiting Aurora, CO, USA 80045

Study Site 7640001

Study Site 7640001

Active not recruiting Bangkok, THA 10330

Study Site 7640005

Study Site 7640005

Active not recruiting Bangkok, THA 10700

Study Site 7240021

Study Site 7240021

Active not recruiting Barcelona, ESP 08035

Study Site 4220007

Study Site 4220007

Active not recruiting Beirut, LBN 165191

Study Site 2760034

Study Site 2760034

Active not recruiting Bonn, DEU 53127

Study Site 2500015

Study Site 2500015

Active not recruiting Brest, FRA 29609

Interested in learning more?
CSL Behring
Sponsored by CSL Behring

To get started, please choose a location